BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30604550)

  • 1. Image Gallery: Necrolytic migratory erythema associated with glucagonoma.
    Aragón-Miguel R; Prieto-Barrios M; Calleja-Algarra A; Pinilla-Martin B; Rodriguez-Peralto J; Ortiz-Romero P; Rivera-Diaz R
    Br J Dermatol; 2019 Jan; 180(1):e1. PubMed ID: 30604550
    [No Abstract]   [Full Text] [Related]  

  • 2. Necrolytic migratory erythema associated with glucagonoma treated successfully with cyclosporine.
    Jiménez-Gallo D; Ossorio-García L; de la Varga-Martínez R; Arjona-Aguilera C; Linares-Barrios M
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28508546
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucagonoma-related necrolytic migratory erythema.
    Bosch-Amate X; Riera-Monroig J; Iranzo Fernández P
    Med Clin (Barc); 2020 Nov; 155(9):418-419. PubMed ID: 31515063
    [No Abstract]   [Full Text] [Related]  

  • 4. Necrolytic migratory erythema and glucagonoma rising from pancreatic head.
    Tseng HC; Liu CT; Ho JC; Lin SH
    Pancreatology; 2013; 13(4):455-7. PubMed ID: 23890147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagonoma syndrome with necrolytic migratory erythema as initial manifestation.
    Zhu WF; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2021 Dec; 20(6):598-600. PubMed ID: 34544669
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucagon cell adenomatosis: a new entity associated with necrolytic migratory erythema and glucagonoma syndrome.
    Otto AI; Marschalko M; Zalatnai A; Toth M; Kovacs J; Harsing J; Tulassay Z; Karpati S
    J Am Acad Dermatol; 2011 Aug; 65(2):458-459. PubMed ID: 21763589
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucagonoma syndrome associated with necrolytic migratory erythema.
    Cardoso Filho Fde A; Feitosa RG; Fechine CO; Matos CM; Cardoso AL; Cardoso DL
    Rev Assoc Med Bras (1992); 2015; 61(3):203-6. PubMed ID: 26248239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Clearance of Necrolytic Migratory Erythema Following Intravenous Administration of Amino Acids.
    Thomaidou E; Nahmias A; Gilead L; Zlotogorski A; Ramot Y
    JAMA Dermatol; 2016 Mar; 152(3):345-6. PubMed ID: 26581030
    [No Abstract]   [Full Text] [Related]  

  • 9. [Necrolytic migratory erythema in a patient with a glucagonoma].
    Demirbas M; Prens B
    Ned Tijdschr Geneeskd; 2021 Oct; 165():. PubMed ID: 34854628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necrolytic migratory erythema: A diagnostic clue in glucagonoma syndrome.
    Moreno-Suárez F; Pulpillo-Ruiz Á; Fontillón Alberdi M
    Med Clin (Barc); 2017 Apr; 148(8):e45. PubMed ID: 27567335
    [No Abstract]   [Full Text] [Related]  

  • 11. A serpiginous eruption.
    Esdaile BA; Hollowood K; Burge S
    Arch Dermatol; 2012 Mar; 148(3):385-90. PubMed ID: 22431782
    [No Abstract]   [Full Text] [Related]  

  • 12. Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome.
    Halvorson SA; Gilbert E; Hopkins RS; Liu H; Lopez C; Chu M; Martin M; Sheppard B
    J Gen Intern Med; 2013 Nov; 28(11):1525-9. PubMed ID: 23681843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrolytic migratory erythema and pancreatic glucagonoma.
    Rodríguez G; Vargas E; Abaúnza C; Cáceres S
    Biomedica; 2016 Jun; 36(2):176-81. PubMed ID: 27622478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychiatric symptoms, skin disease, and weight loss: necrolytic migratory erythema and a glucagonoma.
    Boujan N; Géraud C
    Lancet; 2020 Mar; 395(10228):985. PubMed ID: 32199485
    [No Abstract]   [Full Text] [Related]  

  • 15. [Necrolytic migratory erythema revealing glucagonoma syndrome].
    Maouni S; Elanzi W; Sqalli A; Elmeknassi I; Meziane M; Benzekri L; Hassam B; Senouci K
    Ann Dermatol Venereol; 2019 May; 146(5):419-421. PubMed ID: 30910336
    [No Abstract]   [Full Text] [Related]  

  • 16. Necrolytic Migratory Erythema Associated with a Glucagonoma.
    Banerjee A; Shah SR
    N Engl J Med; 2020 Aug; 383(6):e39. PubMed ID: 32757527
    [No Abstract]   [Full Text] [Related]  

  • 17. A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema.
    Tolliver S; Graham J; Kaffenberger BH
    Int J Dermatol; 2018 Jun; 57(6):642-645. PubMed ID: 29450880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necrolytic migratory erythema: a common cutaneous clue of uncommon syndromes.
    Stavropoulos PG; Papafragkaki DK; Avgerinou G; Papafragkakis H; Katsavou A; Katsambas AD
    Cutis; 2013 Nov; 92(5):E1-4. PubMed ID: 24343217
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucagonoma Syndrome: A Rare Paraneoplastic Disorder due to Neuroendocrine Tumor of the Pancreas.
    Yusuf MA; Mehmood S; Iftikhar J; Saqib M; Siddique MZ; Imtiaz W
    J Coll Physicians Surg Pak; 2022 Aug; 32(8):S147-S149. PubMed ID: 36210677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
    Tremblay C; Marcil I
    J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.